Humanin vs NAD+ Precursors
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: HN, HNG (S14G-humanin)
Humanin is a 24-amino-acid peptide encoded inside mitochondrial DNA (in the 16S rRNA gene), discovered in 2001 and named for its ability to protect human neurons from Alzheimer-related cell death. It was the first member of the mitochondrial-derived peptide family and is studied mainly for neuroprotection, cell survival, and metabolic and age-related disease. The honest status: it has the deepest preclinical evidence base of any mitochondrial peptide, but human therapeutic trials are essentially absent.
Also: NMN, NR
NAD+ precursors are not peptides. They are small molecules, mainly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), that the body converts into NAD+, a coenzyme every cell needs to make energy and run repair enzymes. NAD+ falls with age, so these precursors are sold as anti-aging and metabolic supplements. Human trials confirm they reliably raise blood NAD+ levels, but clear proof of real health benefits in people is still missing.
Key Comparison Insights
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
- NAD+ Precursors has stronger research evidence (Human Trials) compared to Humanin (Animal Studies).
Detailed Comparison
| Attribute | Humanin | NAD+ Precursors |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Humanin is fundamentally a cell-survival signal that blocks apoptosis, the programmed self-destruct cells run when stressed. It binds a trimeric receptor complex made of CNTFR, WSX-1, and gp130 on the cell surface, switching on JAK2/STAT3 survival signaling. Inside the cell it directly grabs the pro-apoptotic protein BAX and stops it from moving to the mitochondria and punching holes in the membrane, which is the step that would otherwise commit the cell to death. It also binds IGFBP-3, modulating IGF-1 signaling and further dialing down apoptosis, and it interacts with formyl peptide receptors. The throughline across all of these is the same: keep stressed cells alive and protect mitochondria. | NAD+ is a workhorse coenzyme for cellular energy metabolism and for enzymes like sirtuins and PARPs that handle DNA repair and stress response. The body builds NAD+ along the salvage pathway: the enzyme NAMPT turns nicotinamide into NMN, and NMNAT enzymes then convert NMN into NAD+. NR enters this route one step upstream, getting phosphorylated into NMN before becoming NAD+. The logic of supplementing is simple: feed the pathway more raw material and you raise the NAD+ pool that declines with age. One wrinkle from recent human work is that gut bacteria may convert some NR and NMN into nicotinic acid before it ever reaches tissues, so the real-world route to higher NAD+ is messier than the textbook diagram. |
| Common Dosing | 5-10 mg weekly divided into 2-3 injections 2-3x weekly (e.g., Monday, Wednesday, Friday) | Limited community data available See research protocols |
| Administration | Injection (route varies) | Oral (capsules, sublingual) |
| Typical Duration | Variable | Ongoing supplementation |
| Best Time to Take | Morning | Morning or before bed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Humanin is one of the best-characterized mitochondrial peptides in the lab, with a large body of in vitro and animal work. It protects neurons against amyloid-beta toxicity, shields retinal pigment epithelium cells from oxidative stress and senescence, and shows protective effects in models of cardiovascular disease and diabetes. Circulating humanin declines with age in humans, and some studies link higher endogenous levels to better metabolic and longevity markers, which fuels the longevity interest. But that is association and animal data, not proof that taking humanin treats any disease. There are no large completed randomized human trials demonstrating clinical benefit, and most of what is sold to consumers is synthetic humanin or analogues like HNG, used far ahead of the evidence. It is a compelling research molecule, not a validated drug. | The one thing human trials agree on is that these precursors work as NAD+ boosters: randomized placebo-controlled studies show chronic NR is well tolerated and raises NAD+ in healthy middle-aged and older adults, and head-to-head work found NR and NMN both roughly doubled circulating NAD+ over about two weeks, while plain nicotinamide did not. The harder question is whether that biochemical bump translates into anything you would feel. A meta-analysis of NAD+ precursor effects on glucose and lipid metabolism found inconclusive, modest, and inconsistent results, and outcomes vary a lot between people depending on age, health, genetics, and gut microbiome. So the accurate framing is: yes, they raise NAD+ and appear safe short term, but robust evidence that they slow aging, improve metabolic disease, or extend healthspan in humans does not yet exist. Most of the dramatic claims come from mouse studies, not people. |
Frequently Asked Questions: Humanin vs NAD+ Precursors
What is the difference between Humanin and NAD+ Precursors?
Humanin is a anti-aging peptide that humanin is a 24-amino-acid peptide encoded inside mitochondrial dna (in the 16s rrna gene), discovered in 2001 and named for its ability to protect human neurons from alzheimer-related cell death. it was the first member of the mitochondrial-derived peptide family and is studied mainly for neuroprotection, cell survival, and metabolic and age-related disease. the honest status: it has the deepest preclinical evidence base of any mitochondrial peptide, but human therapeutic trials are essentially absent. NAD+ Precursors is a anti-aging peptide that nad+ precursors are not peptides. they are small molecules, mainly nicotinamide riboside (nr) and nicotinamide mononucleotide (nmn), that the body converts into nad+, a coenzyme every cell needs to make energy and run repair enzymes. nad+ falls with age, so these precursors are sold as anti-aging and metabolic supplements. human trials confirm they reliably raise blood nad+ levels, but clear proof of real health benefits in people is still missing. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Humanin or NAD+ Precursors?
Neither is universally "better" - the choice depends on your specific goals. Humanin is typically used for anti-aging purposes, while NAD+ Precursors is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Humanin and NAD+ Precursors be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Humanin and NAD+ Precursors together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.